Sandia Home Infusion & Pharmac is categorized under in Albuquerque, NM and active since 2007.
Sandia Home Infusion & Pharmac was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 446110 by the NAICS.
If you are seeking more information, feel free to contact Catherine Estherheld at the company’s single location by writing to 3007 San Pedro Drive Ne, Albuquerque, New Mexico NM 87110 or by phoning (913) 757-4575. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sandia Home Infusion & Pharmac |
| Contact Person: | Catherine Estherheld |
| Address: | 3007 San Pedro Drive Ne, Albuquerque, New Mexico 87110 |
| Phone Number: | (913) 757-4575 |
| Website Address: | yellowpages.kob.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 446110 |
| Share This Business: |
Sandia Home Infusion & Pharmac was started in 2007 to provide professional under the SIC code 5912 and NAICS code 446110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Catherine Estherheld for inquiries that concern Sandia Home Infusion & Pharmac by calling the company number (913) 757-4575, as your correspondence is most welcome. Additionally, the physical location of the single location of Sandia Home Infusion & Pharmac can be found at the coordinates 35.117009,-106.577783 as well as the street address 3007 San Pedro Drive Ne in Albuquerque, New Mexico 87110.
For its online presence, you may visit Sandia Home Infusion & Pharmac’s website at yellowpages.kob.com and engage with its social media outlets through on Twitter and on Facebook.